← Back to headlines
L.B. Foster and ADC Therapeutics Report Earnings, Outlooks
L.B. Foster and ADC Therapeutics both released their latest financial results, with L.B. Foster exceeding revenue and EPS expectations while reaffirming its 2026 outlook. ADC Therapeutics also beat revenue and EPS estimates, setting ambitious peak revenue targets for its drug ZYNLONTA.
4 May, 14:34 — 4 May, 14:34
Sources
Showing 1 of 1 sources
